Effect of Methylprednisolone on Glucose Homeostasis in Patients Undergoing Total Hip- and Knee-arthroplasty
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the pathophysiological effects of a single dose of Methylprednisolone
administered prior to total hip- and knee-arthroplasty surgery. The investigators examine the
effect on blood glucose homeostasis.
Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will
receive placebo.
The investigators hypothesize that the glucose homeostasis remains equally stable in the
group receiving Methylprednisolone as in the group receiving placebo.